Pharmaxis Sells Bronchitol and Aridol Australian Distribution Rights for A$2m
1st
Jul 21
Release Date: 01/07/2021 8:24am
- Pharmaxis sells Australian distribution rights for Bronchitol®and Aridol® in Australia, New Zealand and several Asian territories to BTC Health effective July 1st, 2021
- $2m distributor appointment fee to be paid to Pharmaxis
- Streamlining mannitol respiratory business in line with strategy
Categories: News and Media